24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
03/01/2020
AllRead MLT, a success story originated from the PRUAB’s Ideas Generation Program
06/11/2019
SENER, a top-class aerospace systems provider
29/10/2019
The ICN2 research center is involved in the quantum revolution
21/10/2019
Stradivarius keeps growing
19/09/2019
The president of Catalonia visited the Barcelona Synchrotron Park
12/09/2019
Alba, a tool to tackle challenges in the fields of renewable energy production and fight against air pollution